1. Home
  2. VCYT vs PBI Comparison

VCYT vs PBI Comparison

Compare VCYT & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • PBI
  • Stock Information
  • Founded
  • VCYT 2006
  • PBI 1920
  • Country
  • VCYT United States
  • PBI United States
  • Employees
  • VCYT 824
  • PBI N/A
  • Industry
  • VCYT Medical Specialities
  • PBI Office Equipment/Supplies/Services
  • Sector
  • VCYT Health Care
  • PBI Miscellaneous
  • Exchange
  • VCYT Nasdaq
  • PBI Nasdaq
  • Market Cap
  • VCYT 2.4B
  • PBI 2.2B
  • IPO Year
  • VCYT 2013
  • PBI N/A
  • Fundamental
  • Price
  • VCYT $30.22
  • PBI $11.28
  • Analyst Decision
  • VCYT Buy
  • PBI
  • Analyst Count
  • VCYT 9
  • PBI 0
  • Target Price
  • VCYT $39.89
  • PBI N/A
  • AVG Volume (30 Days)
  • VCYT 2.4M
  • PBI 4.2M
  • Earning Date
  • VCYT 08-06-2025
  • PBI 07-30-2025
  • Dividend Yield
  • VCYT N/A
  • PBI 2.84%
  • EPS Growth
  • VCYT N/A
  • PBI N/A
  • EPS
  • VCYT 0.34
  • PBI N/A
  • Revenue
  • VCYT $479,129,000.00
  • PBI $1,970,913,000.00
  • Revenue This Year
  • VCYT $12.57
  • PBI N/A
  • Revenue Next Year
  • VCYT $10.23
  • PBI $0.40
  • P/E Ratio
  • VCYT $90.02
  • PBI N/A
  • Revenue Growth
  • VCYT 19.91
  • PBI N/A
  • 52 Week Low
  • VCYT $22.61
  • PBI $6.22
  • 52 Week High
  • VCYT $47.32
  • PBI $13.11
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 67.14
  • PBI 47.81
  • Support Level
  • VCYT $26.61
  • PBI $10.92
  • Resistance Level
  • VCYT $30.73
  • PBI $11.71
  • Average True Range (ATR)
  • VCYT 1.17
  • PBI 0.48
  • MACD
  • VCYT 0.75
  • PBI -0.07
  • Stochastic Oscillator
  • VCYT 93.47
  • PBI 26.30

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.

Share on Social Networks: